Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success

Transplantation

Volumn 89, Issue 4, 2010, Pages 465-471

  Koh, Angela ^a   Senior, Peter ^a   Salam, Abdul ^a   Kin, Tatsuya ^a   Imes, Sharleen ^a   Dinyari, Parastoo ^a   Malcolm, Andrew ^a   Toso, Christian ^a   Nilsson, Bo ^a   Korsgren, Olle ^b   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Islet transplantation; Single donor

Indexed keywords

ALEMTUZUMAB; DACLIZUMAB; HEPARIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS ISLET GRAFT REJECTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; ANTITHROMBINS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PERIOPERATIVE CARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THROMBIN; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77649098989     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c478fd     Document Type: Article

References (27)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free im-munosuppressive regimen. N Engl J Med 2000; 343:230.
2. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
3. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N. Engl J Med 2006; 355: 1318.
4. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
5. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955.
6. Matsumoto S, Yamada Y, Okitsu T, et al. Simple evaluation of engraft-ment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc 2005; 37: 3435.
7. Cabric S, Sanchez J, Lundgren T, et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007; 56: 2008.
8. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
9. Rickels MR, Schutta MH, Markmann JF, et al. {beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005; 54: 100.
10. Johansson H, Goto M, Dufrane D, et al. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006; 6: 305.
11. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 1907.
12. Mousa SA. Heparin, low molecular weight heparin and derivatives in thrombosis, angiogenesis and inflammation: Emerging links. Semin Thromb Hemost 2007; 33: 524..
13. Sigrist S, Oberholzer J, Bohbot A, et al. Activation of human macro-phages by allogeneic islet preparations: Inhibition by AOP-RANTES and heparinoids. Immunology 2004; 111: 416.
14. Jansson L, Eizirik DL, Pipeleers DG, et al. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest 1995; 96: 721.
15. Montana E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 1993; 91:780.
16. Menger MD, Vajkoczy P, Leiderer R, et al. Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Invest 1992; 90:1361.
17. Brown RJ, Rother KI. Effects of beta-cell rest on beta-cell function: A review of clinical and preclinical data. Pediatr Diabetes 2008; 9(3 pt 2): 14.
18. Ar'Rajab A, Ahren B. Prevention of hyperglycemia improves the long-term result of islet transplantation in streptozotocin-diabetic rats. Pancreas 1992; 7: 435.
19. Merino JF, Nacher V, RaurellM, et al. Improved outcomeof islet transplantation in insulin-treated diabetic mice: Effects on beta-cell mass and function. Diabetologia 1997; 40: 1004.
20. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hy-perglycemia. Diabetes 2002; 51:66.
21. Weng J, Li Y, Xu W, et al. Effect ofintensive insulin therapyonbeta-cell function and glycaemic controlin patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial. Lancet 2008; 371: 1753.
22. Aljada A, Ghanim H, Mohanty P, et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002; 87: 1419.
23. Aljada A, Ghanim H, Mohanty P, et al. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloprotein-ase in mononuclear cells, and in plasma tissue factor and matrix met-alloproteinase concentrations. Am J Clin Nutr 2004; 80: 51.
24. Dandona P, Chaudhuri A, Mohanty P, et al. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007; 10: 511.
25. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endo-crinol Metab 2001; 86: 3257.
26. Kim S, Millet I, Kim HS, et al. NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 2007; 104: 1913.
27. Shapiro AM, Ricordi C. Unraveling the secrets of single donor success in islet transplantation. Am J Transplant 2004; 4: 295.